Empaglin Duo Tablet 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
MFDS item code 202302758 · Approved 2023.09.14
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps control blood sugar in adults with type 2 diabetes by using Empagliflozin and Metformin together. It can be administered as an adjunct to diet and exercise for effective blood sugar management. It is particularly suitable for adult patients whose blood sugar is not adequately controlled, and caution is needed when used in cases of cardiovascular disease. Clinical trial information can provide more details on the incidence of cardiovascular events. This medication is helpful in controlling blood sugar and preventing related complications in patients with type 2 diabetes.
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should take the same doses of empagliflozin and metformin as before. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the initial dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that can be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication may cause a rare side effect called severe lactic acidosis, so caution should be exercised, especially in patients with impaired kidney function, heart disease, liver disease, and others. Additionally, when taken with insulin or sulfonylurea medications, there is a risk of hypoglycemia, so blood sugar changes should be closely monitored. This medication should not be used in patients with moderate to severe renal impairment or in conditions such as acute infection, heart failure, or acute myocardial infarction. Patients receiving iodine contrast used for radiological examinations should stop taking this medication for a certain period before and after the test, and restart only after normal kidney function is confirmed. Patients undergoing surgery should also stop taking this medication 48 hours prior to surgery and resume after confirming normal kidney function post-surgery. Pregnant women or those who may become pregnant, as well as nursing mothers, should avoid taking this medication for safety. This medication can cause a decrease in fluid volume, so patients with dehydration symptoms or gastrointestinal disorders should exercise particular caution, and elderly patients or those with cardiovascular diseases should regularly monitor blood pressure and kidney function. While on this medication, urinary tract infections or genital infections may occur, so if symptoms arise, a doctor should be consulted immediately. This medication may lower Vitamin B12 levels, so regular blood tests for monitoring are necessary. In case of overdose, serious side effects such as lactic acidosis may occur, so it is important to adhere to the prescribed dosage and consult healthcare personnel immediately if abnormal symptoms occur. Finally, keep this medication out of reach of children and store it in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and the storage temperature should be maintained between 1 degree and 30 degrees Celsius. It is important to avoid direct sunlight and not to place it in overly hot or cold places.
Biconvex oval film-coated tablet with dark brownish purple color
10 tablets/box [(10 tablets/PTP×1)], 60 tablets/box [(10 tablets/PTP×6)], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.